GlaxoSmithKline reached a $105 million settlement with Georgia and 44 other states this week for misrepresenting uses and qualities of its drugs Advair, Paxil and Wellbutrin.
June 05, 2014 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
GlaxoSmithKline reached a $105 million settlement with Georgia and 44 other states this week for misrepresenting uses and qualities of its drugs Advair, Paxil and Wellbutrin.
Georgia will get $2.62 million from the settlement, said John Sours, the administrator of the Governor’s Office of Consumer Protection. The money goes in the state’s general fund. The Office of Consumer Protection is charged with prosecuting violations of the Fair Business Practices Act.
Presented by BigVoodoo
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
